This Edition
ARTICLE | Distillery Therapeutics
MECP2 overexpression disrupts neural progenitor cell fate programs
BC Staff
June 2, 2026 11:23 PM UTC
BCIQ Target Profiles
Methyl CpG binding protein 2 (MECP2) (RTT)
BCIQ Target Profiles
Methyl CpG binding protein 2 (MECP2) (RTT)